Psychotic Disorders  >>  lisdexamfetamine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lisdexamfetamine / Generic mfg.
NCT01093963: Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

Terminated
3
25
US
Lisdexamfetamine, Placebo
Lindner Center of HOPE, Shire, University of Cincinnati
Bipolar Depression
02/14
02/14

Download Options